Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C | NEJM
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
June 27-29 (EDT), June 28-30 (JST), 2024Kyoto Tokyu HotelKyoto, Japan On-Demand: On-demand streaming will be available until September 30, 23:59 (JST). Conference Chairs Luis A.…
Quick Take Video Summary from The New England Journal of Medicine — Thrombectomy for Large Stroke of Unrestricted Size
Much of what we learned in school about how we taste is wrong. Progress in understanding how taste works is providing insights that may help…
A 62-year-old man presented with a 1-month history of muscle aches in the legs and weight loss. Abdominal angiography revealed aneurysms and irregularity of the…
A 47-year-old man was incidentally found to have diffuse nodular opacities on chest radiography. He had worked in a quarry for more than 30 years.
Hounded by questions about her love life, a young physician finds relief in the isolation imposed by the Covid pandemic, while she gains an education…
A 62-year-old man presented with a 1-month history of muscle aches in the legs and weight loss. Abdominal angiography revealed aneurysms and irregularity of the…
Editorial from The New England Journal of Medicine — Cell-free DNA for Colorectal Cancer Screening
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats…
U.S. health plans that aim to address members’ social needs face a host of regulatory obstacles whose management requires deep engagement by institutional compliance offices.